Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp. – GlobeNewswire
- Humacyte raises $245M gross proceeds
- Combined company is expected to begin trading on the Nasdaq Global Select Market® under HUMA and HUMAW on August 27, 2021
- Company well-positioned to deliver on promise of regenerative tissue HAV technology for initial…
